Autonomy of the renin system in type II diabetes mellitus: Dietary sodium and renal hemodynamic responses to ACE inhibition

Kidney International

Volumn 52, Issue 3, 1997, Pages 771-777

  De'Oliveira, Jose Mario ^a   Price, Deborah A ^a   Fisher, Naomi D L ^a   Allan, Donald R ^a   Mcknight, John A ^a   Williams, Gordon H ^a   Hollenberg, Norman K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Angiotensin converting enzyme; Diabetes mellitus; Diet and hemodynamics; Renin system

Indexed keywords

ENALAPRIL;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; SODIUM INTAKE;

EID: 0030763211     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.394     Document Type: Article

References (38)

1. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
2. MARRE M, BERNADET P, GALLOIS Y, SAVAGNER F, GUYENE TT, HALLAR M, CAMBIEN F, PASSA P, ALHENC-GELAS F: Relationship between Ang I converting enzyme gene polymorphism, plasma levels, and diabetic complications. Diabetes 43:384-388, 1994
3. BJORCK S: The renin-angiotensin system in diabetes mellitus: A physiological and therapeutic study. Scand J Urol Nephrol 126(Suppl): 1-50, 1990
4. WILLIAMS GH, DLUHY RG, LIFTON RP, MOORE TJ, GLEASON R, WILLIAMS R, HUNT SC, HOPKINS PN, HOLLENBERG NK: Nonmodulation as an intermediate phenotype in essential hypertension. Hypertension 20:788-796, 1992
5. NATIONAL DIABETES DATA GROUP: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
6. TUCK ML, WILLIAMS GH, CAIN JP, SULLIVAN JM, DLUHY RG: Relation of age, diastolic pressure and known duration of hypertension to presence of low renin hypertension. Am J Cardiol 55:112-117, 1973
7. SHOBACK DM, WILLIAMS GH, HOLLENBERG NK, DAVIES RO, MOORE TJ, DLUHY RG: Endogenous Ang II as a determinant of sodium modulated changes in tissue responsiveness to Ang II in normal man. J Clin Endocrinol Metab 57:764-770, 1983
8. EMANUEL R, CAIN JP, WILLIAMS GH: Double antibody radioimmunoassay of renini activity and Ang II in human peripheral plasma. J Lab Clin Med 81:632-640, 1973
9. UNDERWOOD RH, WILLIAMS GH: The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis. J Lab Clin Med 70:848-862, 1972
10. MOORE TJ, CRANTZ FR, HOLLENBERG NK: Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension 3:168-173, 1981
11. WAEBER B, JUILLERAT-JEANNERET L, AUBERT JF, SCHAPIRA M, NUSSBERGER J, BRUNNER HR: Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin-converting enzyme inhibitors. Br J Clin Pharmacol 27:1758-1805, 1989
12. MEGGS LG, KATZBERG RW, DELEEUW P, HOLLENBERG NK: Specific desensitization of the canine renal vasculature to Ang II despite cyclo-oxygenase inhibition. Yale J Biol Med 58:453-458, 1985
13. HOLLENBERG NK, FISHER NDL: Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word? Hypertension 26:602-609, 1995
14. REDGRAVE J, RABINOWE S, HOLLENBERG NK, WILLIAMS G: Correction of abnormal renal blood flow response to angiotensin II by converting-enzyme inhibition in essential hypertensives. J Clin Invest 4:1285-1290, 1985
15. KOMERS R, COOPER ME: Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: Role of kinins. Am J Physiol 268:F588-F594, 1995
16. MOGENSEN CE: Renoprotective role of ACE inhibitors in diabetic nephropathy. Br Heart J 72(Suppl):38-45, 1994
17. EDIGO J: Vasoactive hormones and renal sclerosis. (Nephrology Forum) Kidney Int 49:478-597, 1996
18. EPSTEIN ME, SOWERS JR: Diabetes mellitus and hypertension. Hypertension 19:403-418, 1992
19. BERETTA-PICCOLI C, WEIDMANN P: Body sodium blood volume state in nonazotemic diabetes mellitus. Miner Electrol Metab 7:36-37, 1982
20. PEREZ GO, LESPIER L, JACOBI J: Hyporeninemia and hypoaldosteronism in diabetes mellitus. Arch Intern Med 137:852-855, 1977
21. CHRISTLIEB AR: Nephropathy, the renin system, and hypertensive vascular disease in diabetes mellitus. Cardiovasc Med 2:417-431, 1978
22. PRICE D, DEOLIVEIRA J, FISHER N, WILLIAMS G, HOLLENBERG N: Renin system autonomy in NIDDM. (abstract) J Am Soc Nephrol 7:1363, 1996
23. LARAGH JH, SEELEY JE: Renin system understanding for analysis and treatment of hypertensive patients: A means to quantify vasoconstrictor elements, diagnose curable renal and adrenal causes, assess risk of cardiovascular morbidity and find the best fit drug regimen, in Hypertension: Pathophysiology, Diagnosis and Management, edited by LARGH JH, BRENNER BM, New York, Raven Press, 1995
24. LUSH DJ, KING JA, FRAY JCS: Pathophysiology of low renin syndromes: Sites of renal renin secretory impairment and prorenin overexpression. Kidney Int 43:983-999, 1993
25. WEIDMANN P, FERRARI P, SHAW SG: Renin in diabetes mellitus (chapt 75), in The Renin-Angiotensin System, edited by ROBERTSON JIS, NICHOLLS MG, New York, Raven Press Ltd., 1993, pp 75.1-75.26
26. TRUJILLO A, EGGENA P, BARRETT J, TUCK M: Renin regulation in Type II diabetes mellitus: Influence of dietary sodium. Hypertension 13:200-205, 1989
27. FELDMAN R, SENDER AJ, SIEGELAUB AB: Difference in diabetic and non-diabetic fat distribution pattern by skinfold measurements. Diabetes 18:478-486, 1969
28. SCHMIEDER RE, BELL AH, WEIHPRECHT H, MESSERLI FH: How should renal hemodynamic data be indexed in obesity? J Am Soc Nephrol 5:1709-1713, 1995
29. VORA JP, DOLBEY J, DEAN JD, THOMAS D, WILLIAMS JD, OWENS DR, PETERS JR: Renal hemodynamics in newly presenting non-insulin dependent diabetes. Kidney Int 41:829-835, 1992
30. NOWACK R, RAUM E, BLUM W, RITZ E: Renal hemodynamics in recent onset Type II diabetes. Am J Kid Dis 20:342-347, 1992
31. HOLLENBERG NK, WILLIAMS GH: Abnormal renal function, sodium-volume homeostasis and renin system hypertension: The evolution of the nonmodulator concept, in Hypertension: Pathophysiology, Diagnosis, and Management (vol 2, 2nd ed, chapt 108), edited by LARAGH JH, BRENNER BM, New York, Raven Press, 1995, pp 1837-1856
32. PERNEGER TV, BRANCATI FL, WHELTON PK, KLAG MJ: End-stage renal diseease attributable to diabetes mellitus. Ann Intern Med 121:912-918, 1994
33. KIKKAWA R, KITAMURA E, FUJIWARA Y, HANEDA M, SHIGETA Y: Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats. Renal Physiol 9:187-192, 1986
34. BALLERMAN B, SKORECKI KL, BRENNER BM: Reduced glomerular Ang II receptor density in early untreated diabetes mellitus in the rat. Am J Physiol 247:F110-F116, 1984
35. WILKES BM: Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: Time course and mechanism. Endocrinology 120:1291-1298, 1987
36. SLATAPER R, VICKNAIR N, SADLER R, BAKRIS GL: Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 153:973-980, 1993
37. LEBOVITZ HE, WIEGMANN TB, CNAAN A, SHAHINFAR S, SICA DA, BROADSTONE V, SCHWARTZ SL, MENGEL MC, SEGAL R, VERSAGGI JA, BOLTON WK: Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria. Kidney Int 45(Suppl 45):S-150-S-155, 1994
38. RAVID M, LANG R, RACHMANI R, LISHNER M: Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med 156:286-289, 1996